A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation - PubMed (original) (raw)

. 2002 Oct 11;277(41):38746-54.

doi: 10.1074/jbc.M205312200. Epub 2002 Jul 22.

Affiliations

• PMID: 12138111
• DOI: 10.1074/jbc.M205312200

Free article

A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation

Taiping Chen et al. J Biol Chem. 2002.

Free article

Abstract

Previous studies have shown that the Dnmt3b gene encodes multiple variants via alternative splicing. However, only one form of Dnmt3a has been identified to date. We report here the discovery of a small form of Dnmt3a, denoted Dnmt3a2, from both human and mouse. The transcript encoding Dnmt3a2 is initiated from a downstream intronic promoter. As a result, the Dnmt3a2 protein lacks the N-terminal 223 (human) or 219 (mouse) amino acid residues of the full-length Dnmt3a. Recombinant Dnmt3a2 protein displayed similar cytosine methyltransferase activity as Dnmt3a in vitro. However, Dnmt3a and Dnmt3a2 exhibited strikingly different subcellular localization patterns. Unlike Dnmt3a, which was concentrated on heterochromatin, Dnmt3a2 displayed a localization pattern suggestive of euchromatin association. Dnmt3a2 is the predominant form in embryonic stem cells and embryonal carcinoma cells and can also be detected from testis, ovary, thymus, and spleen, whereas Dnmt3a is expressed at low levels ubiquitously. Comparison of human embryonal carcinoma cell lines with breast/ovarian cancer cell lines indicates that DNMT3A2 expression correlates with high de novo methylation activity. These findings suggest that Dnmt3a and Dnmt3a2 may have distinct DNA targets and different functions in development.

PubMed Disclaimer

Similar articles

• The inactive Dnmt3b3 isoform preferentially enhances Dnmt3b-mediated DNA methylation.
  Zeng Y, Ren R, Kaur G, Hardikar S, Ying Z, Babcock L, Gupta E, Zhang X, Chen T, Cheng X. Zeng Y, et al. Genes Dev. 2020 Nov 1;34(21-22):1546-1558. doi: 10.1101/gad.341925.120. Epub 2020 Oct 1. Genes Dev. 2020. PMID: 33004415 Free PMC article.
• Identification and characterization of alternatively spliced variants of DNA methyltransferase 3a in mammalian cells.
  Weisenberger DJ, Velicescu M, Preciado-Lopez MA, Gonzales FA, Tsai YC, Liang G, Jones PA. Weisenberger DJ, et al. Gene. 2002 Sep 18;298(1):91-9. doi: 10.1016/s0378-1119(02)00976-9. Gene. 2002. PMID: 12406579
• Dnmt3a2 targets endogenous Dnmt3L to ES cell chromatin and induces regional DNA methylation.
  Nimura K, Ishida C, Koriyama H, Hata K, Yamanaka S, Li E, Ura K, Kaneda Y. Nimura K, et al. Genes Cells. 2006 Oct;11(10):1225-37. doi: 10.1111/j.1365-2443.2006.01012.x. Genes Cells. 2006. PMID: 16999741
• The Roles of Human DNA Methyltransferases and Their Isoforms in Shaping the Epigenome.
  Gujar H, Weisenberger DJ, Liang G. Gujar H, et al. Genes (Basel). 2019 Feb 23;10(2):172. doi: 10.3390/genes10020172. Genes (Basel). 2019. PMID: 30813436 Free PMC article. Review.
• The de novo DNA methyltransferase DNMT3A in development and cancer.
  Chen BF, Chan WY. Chen BF, et al. Epigenetics. 2014 May;9(5):669-77. doi: 10.4161/epi.28324. Epub 2014 Mar 3. Epigenetics. 2014. PMID: 24589714 Free PMC article. Review.

Cited by

• Pan-cancer transcriptome analysis reveals widespread regulation through alternative tandem transcription initiation.
  Zhao Z, Chen Y, Zou X, Lin L, Zhou X, Cheng X, Yang G, Xu Q, Gong L, Li L, Ni T. Zhao Z, et al. Sci Adv. 2024 Jul 12;10(28):eadl5606. doi: 10.1126/sciadv.adl5606. Epub 2024 Jul 10. Sci Adv. 2024. PMID: 38985880 Free PMC article.
• Experimental approaches to the study of epigenomic dysregulation in ageing.
  Thompson RF, Fazzari MJ, Greally JM. Thompson RF, et al. Exp Gerontol. 2010 Apr;45(4):255-68. doi: 10.1016/j.exger.2009.12.013. Epub 2010 Jan 10. Exp Gerontol. 2010. PMID: 20060885 Free PMC article. Review.
• The R882H DNMT3A hot spot mutation stabilizes the formation of large DNMT3A oligomers with low DNA methyltransferase activity.
  Nguyen TV, Yao S, Wang Y, Rolfe A, Selvaraj A, Darman R, Ke J, Warmuth M, Smith PG, Larsen NA, Yu L, Zhu P, Fekkes P, Vaillancourt FH, Bolduc DM. Nguyen TV, et al. J Biol Chem. 2019 Nov 8;294(45):16966-16977. doi: 10.1074/jbc.RA119.010126. Epub 2019 Oct 3. J Biol Chem. 2019. PMID: 31582562 Free PMC article.
• Tumor suppressor CEBPA interacts with and inhibits DNMT3A activity.
  Chen X, Zhou W, Song RH, Liu S, Wang S, Chen Y, Gao C, He C, Xiao J, Zhang L, Wang T, Liu P, Duan K, Cheng Z, Zhang C, Zhang J, Sun Y, Jackson F, Lan F, Liu Y, Xu Y, Wong JJ, Wang P, Yang H, Xiong Y, Chen T, Li Y, Ye D. Chen X, et al. Sci Adv. 2022 Jan 28;8(4):eabl5220. doi: 10.1126/sciadv.abl5220. Epub 2022 Jan 26. Sci Adv. 2022. PMID: 35080973 Free PMC article.
• Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS.
  Wong M, Gertz B, Chestnut BA, Martin LJ. Wong M, et al. Front Cell Neurosci. 2013 Dec 25;7:279. doi: 10.3389/fncel.2013.00279. eCollection 2013. Front Cell Neurosci. 2013. PMID: 24399935 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc
  • Gene Ontology
  • GlyGen glycoinformatics resource
  • Mouse Genome Informatics (MGI)
  • REBASE - The Restriction Enzyme Database

• Research Materials

  • NCI CPTC Antibody Characterization Program